Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/21/2022 | Press release | Distributed by Public on 01/21/2022 16:48
Please select the service you want to use:
Smartlinks | Certara Inc. | News | Finance | Stock Markets | Security Markets | Derivative Securities | Stock Markets | Security Markets | Company News | Shareholders | Buyback, Treasury Shares and Liquidity Agreements | Internal Dealings | Public Companies | Software Companies | NYSE American | NYSE ARCA Equities | Börse Hamburg | Nasdaq Global Select Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact